FDA Brief

Warning letters Drugs

FDA warning letter to

Marcus Research Laboratory, Inc.

Issued Sep 30, 2021Posted Oct 19, 2021Division of Pharmaceutical Quality Operations III

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.